VA researchers have identified 3 genetic mutations that govern cholesterol levels, which could lead to new drugs to treat cardiovascular disease...
A gene mutation that slows sugar metabolism in the gut may lower risk of diabetes, obesity, heart failure, and even death.
NASHVILLE – “We share these patients; let’s work together on trying to make them better,” said Steven Nissen, MD.
Mortality declined dramatically in patients with type 2 diabetes mellitus who took the medication over an average of 3 years.
NIH study looks into the efficacy of gastric banding in stabilizing prediabetes over metformin.
Predictors of HA1c Goal Attainment in Patients Treated With Insulin at a VA Pharmacist-Managed Insulin Clinic
Showing up to appointments and adherence to treatment recommendations correlated with glycemic goal attainment for patients.
Hypoglycemia Safety Initiative: Working With PACT Clinical Pharmacy Specialists to Individualize HbA1c Goals
Clinical pharmacy specialist interventions after patient consultation resulted in statistically significant increases in HbA1c levels in patients...
Evaluating Management and Change in Glycemic Control After Discontinuation of Metformin in Patients With Elevated Serum Creatinine
Recently revised FDA labeling allows many patients with mild-to-moderate kidney disease to benefit from treatment with metformin.